The Business Of Regenerative Medicine

From PharmaLive, a look at the business of regenerative medicine, which "offers the possibility of replacing damaged or diseased cells and tissues. If it were possible to replace insulin secreting cells in the pancreas, type I diabetes could be cured. If it were possible to replace dopamine-secreting cells in the brain, Parkinson's might be cured. Cures, not just palliative treatments, are promised by regenerative medicine. ... There are over 200 tissue types in the human body; the loss or degeneration of any individual type is likely to cause disease or at least unwelcome changes in appearance. ... the worldwide revenues for cell and cytokine therapies in regenerative medicine is estimated at $12.7 billion in 2005. This market is expected to expand to $20.7 billion in 2010, an AAGR (average annual growth rate) of 10.3%." The potential for business success drives private research funding in any field.

Link: http://www.pharmalive.com/News/index.cfm?articleid=281328&categoryid=15